Sanna Bastiano's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed May 4, 2022
- Accession no.
- 0000899243-22-016641
- Filed
- May 4, 2022
- Trade date
- May 2, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions. Open-market sales total $82.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sanna BastianoCIK 0001829069 | Officer (EVP, Cell & Genetic Therapies) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2022 | Common Stock | SSaleDisposed | −20 | $255.47F2,F3 | −$5,109.4 | 41,996 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −90 | $257.49F2,F4 | −$23,174.1 | 41,906 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −43 | $258.46F2,F5 | −$11,113.78 | 41,863 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −75 | $259.58F2,F6 | −$19,468.5 | 41,788 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −23 | $260.44F2,F7 | −$5,990.12 | 41,765 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −65 | $261.79F2,F8 | −$17,016.35 | 41,700 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −4 | $264.37 | −$1,057.48 | 41,696 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Dr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 6 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $255.47 (range $255.23 to $255.70).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $257.49 (range $257.05 to $257.87).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $258.46 (range $258.11 to $258.93).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $259.58 (range $259.24 to $260.07).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $260.44 (range $260.35 to $261.31).
Referenced by the price of 1 transaction in Table I.
- F8
Open market sales reported on this line occurred at a weighted average price of $261.79 (range $261.39 to $262.23).
Referenced by the price of 1 transaction in Table I.